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Self-assemblyDefects in the corneal stroma caused by trauma or diseases such as macular corneal dystrophy and
keratoconus can be detrimental for vision. Development of therapeutic methods to enhance corneal
regeneration is essential for treatment of these defects. This paper describes a bioactive peptide nanoﬁber
scaffold system for corneal tissue regeneration. These nanoﬁbers are formed by self-assembling peptide
amphiphile molecules containing laminin and ﬁbronectin inspired sequences. Human corneal keratocyte
cells cultured on laminin-mimetic peptide nanoﬁbers retained their characteristic morphology, and their
proliferation was enhanced compared with cells cultured on ﬁbronectin-mimetic nanoﬁbers. When these
nanoﬁbers were used for damaged rabbit corneas, laminin-mimetic peptide nanoﬁbers increased kerato-
cyte migration and supported stroma regeneration. These results suggest that laminin-mimetic peptide
nanoﬁbers provide a promising injectable, synthetic scaffold system for cornea stroma regeneration.
 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.1. Introduction
The cornea acts as a barrier to protect the eye from external
effects and has a major role in the refractive nature of the eye
[1]. It is a dome-shaped, transparent, avascular and immune priv-
ileged tissue, which contains three major layers: the outermost
epithelium layer; the stroma; and the innermost endothelium
layer [1–3]. The structure and thickness of these layers are crucial
for the cornea’s transparency. Corneal opaciﬁcation due to inﬂam-
mation, trauma or corneal dystrophies such as keratoconus or
keratoglobus results in vision loss affecting ten million people
worldwide annually, who are generally treated by cornea trans-
plantation [4,5]. Even though the need for cornea donation
increases each year, the number of suitable donors decreases
owing to widespread use of laser vision corrective surgery, which
makes the cornea unusable for transplantation.
The stroma is the thickest part of the cornea. It is formed by
quiescent corneal ﬁbroblasts, keratocytes, which are sandwiched
between collagen lamellae [6]. Uniform spacing between collagen
ﬁbers and their parallel organization are thought to have roles in
corneal transparency and enhanced light transmission. Damageto the ultrastructural organization of the corneal stroma can lead
to irreversible loss of transparency. Stroma thinning, which is
observed in keratoconus, also prevents the cornea from proper
functioning. To address problems associated with corneal stroma,
many different corneal substitutes, such as keratoprosthesis [7]
or tissue engineered corneal equivalents [8], have been con-
structed. Keratoprosthesis has been employed for more than a cen-
tury, but the most promising commercial keratoprostheses [9,10]
were reported to cause progressive stroma melting and epithelial
defects [11]. Various biomaterials have been suggested for use in
tissue engineered corneal equivalents, including collagen [12,13],
ﬁbrin-agarose [14] and decellularized cornea [15]. Because of its
high optical clarity, it is important to design a scaffold that pre-
serves the transparency of the cornea. Moreover, this scaffold
should possess high biocompatibility ad non-immunogenicity [16].
Peptide amphiphile (PA) molecules self-assemble into nanoﬁ-
bers through intermolecular forces [17]. The self-assembly mecha-
nism is based on hydrophobic interactions of alkyl tails,
intermolecular hydrogen bonding and electrostatic interactions
between the charged groups. At physiological pH, electrostatic
interactions between oppositely charged molecules promote self-
assembly without any external trigger [18]. Therefore, oppositely
charged peptides molecules are mixed to form nanoﬁbers at the
physiological pH. The interactions between these nanoﬁbers make
up a three-dimensional (3-D) network, which encapsulates water
and results in a hydrogel structure. Since the peptide segment of
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nanoﬁber networks are promising biomaterials for achieving
controlled cell–material interactions. Because of their versatile
physical, chemical and biological features, they have been used
as synthetic extracellular matrix (ECM) mimicking agents for carti-
lage [19], bone [20] and neural regeneration [21] and angiogenesis
[22]. Various sets of peptide epitopes, which are found in ECM
proteins such as laminin, collagen and ﬁbronectin, are known to
play crucial roles in the maintenance of cell survival and function.
For example, the YIGSR sequence derived from laminin b-chain
regulates cell adhesion through binding to laminin binding protein
[23–25]. As an alternative to YIGSR, the RGD sequence derived
from ﬁbronectin can also be used for attachment of the cells to
the ECM. Previously, RGD-containing peptides were observed to
act as cell adhesive agents when they were immobilized on the
surface [26]. These characteristic sequences regulate biological
activities through activating and/or inhibiting protein targets with
high speciﬁcity [27]. Owing to the short lengths of these peptide
sequences, they are more stable and easier to manipulate, and
show fewer conformational changes compared with whole pro-
teins [28]. Therefore, it is convenient to use such sequences in
pharmaceutical and clinical applications.
Versatile functional groups, the easy implementation capability
and the self-assembly property of PA networks make them prom-
ising biomaterials for corneal tissue engineering. In this study, PA
molecules carrying bioactive peptide sequences, YIGSR and RGD
derived from laminin and ﬁbronectin, were used to induce corneal
regeneration. Healing of corneal wounds depends on the balance
between cellular proliferation, differentiation, apoptosis and
motility in the damaged area. Materials that can regulate these
behaviors simultaneously can mimic the native environment of
cells and play vital roles in the maintenance of normal corneal
function [29].2. Materials and methods
2.1. Materials
The 9-ﬂuorenylmethoxycarbonyl (Fmoc) and other protected
amino acids, lauric acid, [4-[a-(20,40-dimethoxyphenyl) Fmoc-ami-
no methyl] phenoxy] acetomidonorleucyl-MBHA resin (Rink amide
MBHA resin), 2-(1H-Benzotriazol-1-yl)-1,1,3,3-tetramethyluroni-
um hexaﬂuorophosphate (HBTU) and diisopropylethylamine were
purchased from Merck and ABCR. The 100–200 mesh Wang resin
was purchased from NovaBiochem, and valine was loaded on it
for producing Fmoc-Val-Wang resin. All other chemicals and mate-
rials used in this study were analytical grade and obtained from
Invitrogen, Fisher, Merck, Alfa Aesar and Sigma–Aldrich.2.2. Synthesis and puriﬁcation of PA molecules
The YIGSR-PA (Lauryl-VVAGKYIGSR-Am), KKRGD-PA (Lauryl-
VVAGKKRGD-Am), K-PA (Lauryl-VVAGK-Am) and E-PA (Lauryl-
VVAGE-OH) molecules were synthesized using Fmoc solid phase
peptide synthesis. Synthesiswas performedmanually on a 1 mmole
scale using a 50 ml peptide synthesis vessel on awrist action shaker.
Either Fmoc-Glu-(OtBu)-Wang resin or Rink amide resin was used
for synthesis. Before each coupling reaction, Fmoc groups were re-
moved by shaking resin in 20% piperidine in N,N-dimethylformam-
ide (DMF) for 20 min. After each reaction, the resin was washed
three times with DMF, dichloromethane (DCM) and DMF, respec-
tively. All amino acidswere activated by adding 2molar equivalents
of amino acid to 1.95 equivalents of O-Benzotriazole-N,N,N0,N0-tet-
ramethyl-uronium-hexaﬂuoro-phosphate (HBTU) and dissolved in
10 ml of DMF. After complete dissolution of amino acid and HBTUin DMF, 3 molar equivalents of N-ethyl-diisopropylamine were
added to the solution. The solution was mixed thoroughly and kept
for 3 min before adding to the resin. Each coupling reactionwas per-
formed for 2 h. Peptide alkylation reaction was performed by cou-
pling lauric acid to the peptide. A ninhydrin test was performed
after additionof each aminoacid andafter addition of the lauric acid.
When the ninhydrin test yielded positive results, coupling reaction
was repeated; otherwise 10 ml of 10% acetic anhydride/DMF solu-
tionwas added, and the resinwas sha ken for 30 min. Peptide cleav-
age and deprotection were performed with 95:2.5:2.5
triﬂuoroacetic acid (TFA):triisopropylsilane:water for 2 h at room
temperature (RT). After the cleavage reaction, PA molecules were
collected in a clean round-bottomﬂask, and the DCMwashwas per-
formed several times. Collected solution was rotary evaporated.
After evaporation, ice-cold diethyl ether was added, and sample
was left at20 C overnight. The PA–diethyl ether mixture was col-
lected in 50 ml falcon tubes and centrifuged at 6000 rpm for 20 min.
The supernatantwas decanted, and the remaining diethyl etherwas
evaporated. The pellet was dissolved in deionized water at a resis-
tance of 18.2 O and was freeze-dried. Characterization of synthe-
sized PA was done using Agilent 6530 quadrupole time-of-ﬂight
mass spectrometrywith an electrospray ionization source equipped
with reverse-phase analytical high-performance liquid chromatog-
raphy (HPLC) with an Agilent Zorbax Extend-C18 2.1  50 mm col-
umn for basic conditions or a Zorbax SB-C8 4.6  100 mm column
for acidic conditions (Figs. S1–6). A gradient of 0.1% formic acid/
water for acidic conditions or 0.1% ammonium hydroxide/acetoni-
trile for basic conditions was used as mobile phase for analytical
HPLC. An Agilent preparative reverse-phase HPLC system equipped
with a Zorbax Extend-C18 21.2  150 mm column for basic condi-
tions and a Zorbax SB-C8 21.2  150 mm column for acidic condi-
tions were used for the puriﬁcation of PA molecules. The residual
TFA in PA samples was removed by HCl treatment by dissolving in
0.01 M HCl solution and freeze drying. An Agilent preparative
reverse-phase HPLC system equipped with Zorbax Extend-C18
21.2  150 mm column was used for purifying E-PA molecule.2.3. Physical and chemical characterization of PA molecules
In the physical and chemical characterizations of peptide nano-
ﬁber systems used for in vitro studies, negatively charged E-PA was
used as a non-bioactive gelator molecule for mixing with positively
charged YIGSR-PA, KKRGD-PA and K-PA. Nanoﬁbers were formed
through self-assembly of the PA molecules caused by electrostatic
interactions. Since positively charged PA solutions formed gel in
the corneal pocket following injection, owing to the presence of
negatively charged molecules such as chondroitin sulfate (CS)
and keratin sulfate in native cornea, CS was used to induce nanoﬁ-
ber formation with positively charged YIGSR-PA and KKRGD-PA
molecules for characterizing the peptide nanoﬁber systems used
for in vivo studies. In these experiments, the PA molecules were
dissolved in 0.25 M sucrose solution, unless speciﬁed otherwise,
since injections into the cornea were also performed in a similar
manner.2.3.1. Atomic force microscopy
PA solutions were prepared by mixing 0.05 wt.% YIGSR-PA,
KKRGD-PA or K-PA with E-PA at a 2:1 volume ratio, or 0.05 wt.%
YIGSR-PA and KKRGD-PA with 0.1% CS at a 7:1 volume ratio.
Because sucrose solution prevented cantilever mobility, all PA
molecules were dissolved in water. Then, 10 ll of the ﬁnal
solutions were drop-cast on silicon wafers and air dried. Atomic
force microscopy (AFM) images were taken by MFP-30 Asylum
Research in tapping mode, using a cantilever with stiffness
k = 40 N m1 and resonance frequency f = 250–350 kHz.
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Transmission electron microscopy (TEM) samples were pre-
pared on a Lacey carbon-coated 300-mesh copper grid, and 10 ll
of the solutions were dropped on a grid and incubated for 3 min
before staining. The excess amount was removed by tissue paper,
and 2 wt.% uranyl acetate solution was used for staining the organ-
ic nanostructures. The samples were imaged by FEI Tecnai G2 F30.
2.3.3. Circular dichroism
Circular dichroism (CD) spectra of the PA solutions were ob-
tained on a J-815 Jasco CD spectrophotometer in the far UV region
using quartz cuvettes with a 1 mm path length. The CD spectra of
YIGSR-PA/E-PA, KKRGD-PA/E-PA, K-PA/E-PA, YIGSR-PA/CS and
KKRGD-PA/CS were acquired. For preparation of YIGSR-PA/E-PA,
KKRGD-PA/E-PA and K-PA/E-PA samples, PA molecules were dis-
solved in deionized water at a concentration of 0.01 wt.% and
mixed in a 2:1 ratio. For preparation of YIGSR-PA/CS and KKRGD-
PA/CS samples, PA molecules were dissolved in 0.25 M sucrose
solution at a concentration of 0.01 wt.%, CS was dissolved in deion-
ized water at a concentration of 0.02 wt.%, and they were mixed in
a ratio of 7:1. The pH value of each solution was adjusted to 7.4
with 1 M NaOH before characterization. An average of three scans
of each sample was used. CD spectra were obtained from 190 nm
to 300 nm, using a digital integration time of 1 s, a band width of
1 nm and a data pitch of 0.1 nm.
2.3.4. Scanning electron microscopy
The nanoﬁber network formation of PA molecules was investi-
gated by scanning electron microscopy (SEM) imaging performed
with a FEI Quanta 200 FEG under high vacuum. For preparation
of YIGSR-PA/E-PA, KKRGD-PA/E-PA and K-PA/E-PA samples,
1 wt.% PA solutions were mixed at a ratio of 2:1. For YIGSR-PA/CS
and KKRGD-PA/CS samples, PA solutions and CS solution were
mixed at a volume ratio of 9:1. Gels were incubated for 20 min
for maturation, and dehydrated gradually with increasing concen-
trations of ethanol. Samples were dried in a critical-point dryer
(Tousimis, Autosamdri-815B) and coated with 6 nm of Au/Pd.
2.4. Cell culture and maintenance
The viability, spreading and proliferation proﬁles of cells on PA
molecules were studied using the telomerase immortalized human
corneal keratocyte (HTK) cell line previously developed by Jester
et al. [30]. HTK were cultured in 75 cm2 polystyrene cell culture
ﬂasks with Dulbecco’s Modiﬁed Eagle Medium containing 10% fetal
bovine serum and 1% penicillin/streptomycin [30]. In vitro experi-
ments and passaging of cells were performed when cultures be-
came 80% conﬂuent.
2.4.1. Analysis of in vitro effects of PA molecules
Three experimental groups were designed to assess the biocom-
patibility and bioactivity of PA molecules on HTK cells. While K-PA/
E-PA was used as nanoﬁber control, YIGSR-PA/E-PA and KKRGD-
PA/E-PA were used as bioactive nanoﬁber networks. Collagen
was used as positive control. For in vitro experiments, all positively
charged PA were mixed with negatively charged E-PA. For each
experiment, 0.2 wt.% YIGSR-PA/E-PA, KKRGD-PA/E-PA and K-PA/
E-PA were mixed at 1.85:1, 1.7:1 and 2:1 volume ratios, respec-
tively, and 0.01 wt.% collagen solution was used for collagen-
treated samples. Experiments were performed in 96-well plates
containing 100 ll of total PA solution or 40 ll of collagen solution.
Coated plates were incubated at 37 C for 30 min, and solvents
were evaporated in a laminar ﬂow hood overnight. Before culturing
HTK, plates were UV-sterilized for at least 15 min, then 3  103
HTK were seeded into each well.To determine the viability and proliferation of HTK quantita-
tively, an Alamar blue assay was performed: 3  103 cells were
seeded in 96-well plates and cultured for viability and proliferation
for 24 h and 72 h, respectively. The Alamar blue assay was per-
formed according to manufacturer’s instructions and ﬂuorescence
spectrum was measured at an excitation of 540–570 nm and emis-
sion of 580–610 nm.
2.4.2. Spreading
Spreading of HTK was investigated by staining ﬁlamentous ac-
tins and nuclei with TRITC-conjugated phalloidin and TO-PRO-3
iodide, respectively. In order to evaluate vimentin expression,
which is a keratocyte marker, cells were stained with anti-vimen-
tin antibody, and 15-mm glass cover slips were coated with PA
molecules or collagen as described above. Coated cover slips were
placed in 24-well plates, 2  104 HTK were seeded in each well,
and were incubated for 24 h at 37 C with 5% CO2. Cells were ﬁxed
by treating with 4% paraformaldehyde for 15 min and were
washed three times with PBS. After permeabilization had been per-
formed via 0.1% Triton X-100 treatment in PBS with 1% bovine ser-
um albumin (BSA), samples were incubated in blocking solution for
2 h. At the end of the incubation time, samples were incubated
with anti-vimentin antibody (1:200) overnight at 4 C. Alexaﬂu-
or-488 conjugated secondary antibody was used at 1:500 dilution.
Following the PBS wash, samples were stained with FITC-phalloi-
din (1:500) and TO-PRO-3 iodide (1:1000) for 20 min each at
RT. Samples were mounted with ProLong anti-fade mounting med-
ia and were imaged with Zeiss LSM 510 confocal microscope.
Cell–nanoﬁber interaction was also assessed by electron
microscopy. HTK cultured on PA-coated, collagen-coated and bare
glass surfaces were incubated for 24 h. Fixation with 2.5% gluteral-
dehyde was followed by 1 wt.% OsO4 treatment. Subsequently,
water content was removed by gradual increase of ethanol.
Samples within 100% ethanol were dried with a Tourismis
Autosamdri-815B critical-point dryer. Dried samples were coated
with 4 nm Au/Pd and imaged under high vacuummode SEMwith a
FEI Quanta 200 FEG instrument equipped with an ETD detector.
2.5. In vivo experiments
In vivo experiments were carried out with 15 young adult New
Zealand white rabbits weighing between 2.5 and 3.0 kg. Rabbits
were maintained on ad libitum access to water and nutrition in a
12 h–12 h light–dark cycle. All animal studies were approved by
Mersin University Animal Studies Ethical Committee, and all
experiments were conducted in accordance with the Animal Care
and Use Committee and the ARVO statement for the Use of Animals
in Ophthalmic and Vision Research.
2.5.1. Surgical procedure
YIGSR-PA and KKRGD-PA molecules were dissolved in 0.25 M
sucrose solution and sterilized under UV for 2 h. Rabbits were
anesthetized with an intramuscular injection of 50 mg kg1 keta-
mine hydrochloride and 5 mg kg1 xylazine hydrochloride. Under
general anesthesia, corneal stromal pockets 7–8 mm in diameter
were made by lamellar dissection of the cornea with a ﬁne corneal
spatula, and 1 wt.% PA solutions were injected into corneal stromal
pocket. After injection, the entrance of the corneal stromal pocket
was sutured. In the negative control group, a corneal stromal pock-
et was formed in a similar fashion, and the entrance was sutured
without any injection and is referred to as ‘‘corneal pocket without
injection’’. At the end of surgery, subconjunctival injection of
0.1 ml dexamethasone/netilmicin was carried out. Topical dexa-
methasone/netilmicin (0.1%/0.3%) eye drops were administered
four times a day for 1 week after the procedure. During the study,
all the eyes were examined clinically for corneal clarity and for any
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KKRGD-PA (n = 3; n = 4) injected corneas were surgically removed
after 3 or 7 weeks, for histological and immunohistochemical (IHC)
characterization. Also, corneal pocket without injection (n = 3;
n = 2) and native (n = 2; n = 2) corneas were used as negative and
positive control groups, respectively. All rabbits were sacriﬁced
with an intravenous injection of 100 mg kg1 sodium pentobarbi-
tal. Cornea thickness was measured before and after injection,
and before the cornea excision process via a pachymeter.
2.5.2. Immunohistochemistry
For histological investigation, corneas were ﬁxed in 4% parafor-
maldehyde and embedded in parafﬁn. Tissues were sectioned with
a Leica microtome at 5 lm thickness. Sections were deparafﬁnized
in xylene and rehydrated in serial ethanol series for hematoxyline
and eosin (H&E) staining.
For immunohistochemistry experiments, sections were stained
with anti-collagen I and anti-vimentin antibodies. Following
deparafﬁnization and rehydration steps, antigen retrieval was per-
formed using pepsin at 37 C. Samples were treated with Tris-base
saline (TBS) with 0.025% Triton X-100 twice for 5 min for perme-
abilization. Then, 10% normal serum with 1% BSA in TBS was added
to samples, which were incubated for 2 h at RT in a humidiﬁed
chamber. Primary antibodies for collagen I and vimentin were di-
luted in TBS with 1% BSA at ratios of 1:600 and 1:200, respectively.
Samples were incubated with primary antibody overnight at 4 C.
After incubation, samples were washed twice with 0.025% Triton
X-100 in TBS for 5 min. Alexaﬂuor 488 conjugated goat anti-mouse
IgG (1:600) or Cy2 conjugated goat anti-mouse IgG (1:300) were
used as secondary antibodies. After 1 h of incubation at RT, all sam-
ples were mounted onto glass slides using Prolong anti-fade
mounting media.
2.6. Statistical analyses
Statistical analyses were performed using GraphPad Prism 5. To
determine the statistical difference for both viability and prolifer-
ation assays, one-way ANOVA and Bonferroni’s multiple compari-
son post-tests were employed. Error bars indicate standard error
of mean.3. Results and discussion
3.1. Synthesis of PA molecules
Two different bioactive PA molecules were designed and syn-
thesized and used in in vitro and in vivo experiments (Fig. 1a
and b). YIGSR-PA molecule, which is inspired from laminin, was
designed to enhance cell adhesion and proliferation. Boateng
et al. [23] previously demonstrated that YIGSR affects cell adhesion
on neonatal myocytes and provides resistance to mechanical strain
in cultured cells. In another study, YIGSR epitope was observed to
promote adhesion and proliferation of human skin ﬁbroblasts [29].
Fibronectin, which is an ECM glycoprotein, is involved in cell
attachment like laminin. Since RGD, which is found in the ﬁbronec-
tin sequence, was reported to be important for recognition by inte-
grins [30], KKRGD-PA was used to mimic the cell adhesive function
of ﬁbronectin. K-PA was used as a control nanoﬁber matrix without
YIGSR or RGD epitopes, to test the bioactivity of the PA, and colla-
gen was used as a positive control.
Three-dimensional networks composed of peptide nanoﬁbers
were obtained through inducing self-assembly via mixing two
oppositely charged PA molecules. The PA molecules self-assemble
via electrostatic interactions and hydrophobic collapse at physio-
logical pH, and encapsulation of water in 3-D networks ofnanoﬁbers results in gelation [18]. E-PA is a non-bioactive and
negatively charged molecule (Fig. 1d), which was used for neutral-
ization of positively charged YIGSR-PA, KKRGD-PA and K-PA
molecules.
In vitro studies were carried out with positively charged PA
molecules gelled with negatively charged E-PA addition. For
analysis of the nanoﬁbers that were formed in in vivo studies,
nanoﬁbers were formed by mixing CS with YIGSR-PA and
KKRGD-PA, since the adult human corneal stroma, similar to
rabbit, contains 65 wt.% keratan sulfate and 30 wt.% chondroitin/
dermatan sulfate (CS/DS) [31]. Because these glycosaminoglycans
are highly negatively charged molecules, positively charged PA
molecules formed gels upon injection into cornea.
3.2. Characterization of self-assembled PA nanoﬁbers
Circular dichroism spectroscopy was used to characterize the
formation of peptide nanostructures. The b-sheet secondary struc-
ture was found to be prevalent for all samples, which also indicates
nanoﬁber formation driven by b-sheet structure (Fig. 2) [32]. CD
spectra of PA-CS nanoﬁbers are shown in Fig. S9. Nanoﬁbers that
were formed by b-sheet driven self-assembly of PA molecules were
visualized by TEM and AFM imaging. TEM images of nanoﬁbers
formed with E-PA or CS are shown in Fig. 3b and Fig. S10b and e,
respectively. These images reveal that all the PA combinations that
were used for in vitro and in vivo experiments formed uniform
nanoﬁbers with diameters of 20–30 nm. The ﬁber diameters
were similar for all PA combinations. The bundles formed by PA
nanoﬁbers were analyzed by AFM (Fig. 3c, f, I and Fig. S10c, f).
AFM images revealed that the nanoﬁbers formed by all PA combi-
nations used showed similar heights and morphologies.
The natural ECM is composed of a ﬁbrous network and other
structural and functional components that interact with cells.
The organization of ﬁbrils and lamellae affects the tensile strength
of cornea and its transparency signiﬁcantly [33]. Thus, when devel-
oping synthetic extracellular matrices, mimicking this ﬁbrous net-
work structure is an important task. PA molecules were previously
shown to form nanoﬁbrous networks similar to natural ECM. SEM
imaging was used to investigate the general morphology of the
hydrogels formed by the PA nanoﬁbers. Critical-point drying was
used to preserve the structure of the gels. The SEM images of
YIGSR-PA/E-PA, KKRGD-PA/E-PA, K-PA/E-PA and of YIGSR-PA/CS
and KKRGD-PA/CS nanoﬁber networks are shown in Fig. 3a, d
and g and Fig. S10a and d.
3.3. In vitro characterization of cellular responses on PA nanoﬁbers
The HTK cell line was developed and investigated by Jester et al.
[30]. Karyotype, morphological and physiological analyses showed
that these immortalized cells have similar properties to primary
corneal keratocytes [29]. HTK cells were used in order to investi-
gate the effects of bioactive peptide nanoﬁbers on keratocyte
viability and proliferation in vitro. Cell viability was determined
by Alamar blue assay after culturing cells on the nanoﬁbers for
24 h. Viability results indicated no signiﬁcant difference among
laminin-mimetic YIGSR-PA/E-PA, ﬁbronectin mimetic KKRGD-PA/
E-PA and non-bioactive K-PA/E-PA nanoﬁber scaffolds (Fig. S11),
suggesting that the bioactive sequences did not cause enhanced
viability of corneal ﬁbroblasts. HTK cells cultured on collagen
showed higher viability than all PA groups. This might have been
caused by the fact that collagen, as a natural component of ECM
combines a comprehensive array of biological and mechanical sig-
nals supporting the viability of these cells. In order to analyze the
effects of the bioactive PA on proliferation of HTK cells, the cells
were analyzed by Alamar blue assay after 72 h of incubation. While
HTK cells cultured on laminin mimetic YIGSR-PA/E-PA nanoﬁbers
Fig. 1. Chemical structures of PA molecules: (a) YIGSR-PA; (b) KKRGD-PA; (c) K-PA; (d) E-PA.
Fig. 2. Circular dichroism spectra of the peptide nanostructures. The PA molecules
showed characteristic b-sheet structure at physiological pH.
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K-PA/E-PA nanoﬁbers, it was similar to that of cells on collagen
coated wells (Fig. 4b). However, HTK cells cultured on ﬁbronectin
mimetic KKRGD-PA/E-PA nanoﬁbers exhibited a slower prolifera-
tion rate than cells cultured on control nanoﬁbers.
In their natural milieu, keratocytes need to adhere to the ECM in
order to direct their cellular processes such as survival, migration
or proliferation. When adhesion of cells on laminin mimetic
YIGSR-PA/E-PA or ﬁbronectin mimetic KKRGD-PA/E-PA nanoﬁbers
was investigated through SEM imaging, HTK cells grown on lami-
nin mimetic nanoﬁbers exhibited adhesion and spreading proﬁle
similar to cells cultured on collagen (Fig. 5a, d). However, the
adhesion and spreading proﬁles of cells cultured on ﬁbronectin
mimetic nanoﬁbers were similar to cells cultured on non-bioactiveK-PA/E-PA nanoﬁbers (Fig. 5b, c). Immunohistochemical staining
for vimentin, which is a major structural protein of keratocytes,
also revealed a morphological proﬁle of cells grown on different
scaffolds similar to those observed in the SEM analysis (Fig. 6).3.4. Histological examination and analysis of rabbit corneas
The effects of laminin mimetic and ﬁbronectin mimetic PA gels
on in vivo regeneration of corneal stroma were investigated using a
rabbit corneal stromal pocket model. Corneal stromal pockets were
surgically created as described in the methods section and ﬁlled
with either YIGSR-PA or KKRGD-PA (Fig. 7), or left empty as nega-
tive controls. A pachymeter was employed to measure the central
corneal thickness of the rabbit corneas (n = 5), and changes in the
cornea thickness were investigated before and after injection. Since
the stromal thickness proﬁle provides information about changes
in corneal regeneration [34], measurements were performed at 3
(Fig. S12a) or 7 (Fig. S12b) weeks after surgery before sacriﬁcing
the animals. After injection, there was an average increase of
100 lm and 200 lm in corneal thickness, for YIGSR-PA and
KKRGD-PA treated animals, respectively. However, after 3 weeks,
the increase in corneal thickness of PA injected samples disap-
peared, and no signiﬁcant difference was observed among PA
injected groups, the native group and the corneal pocket without
injection group. Measurements at 7 weeks also revealed a similar
proﬁle.
In order to investigate the regeneration process in PA gel in-
jected and control cornea samples, histological and immunohisto-
chemical analyses were carried out. H&E staining was performed
to observe the morphology of damaged and newly formed ECM
and cell migration after surgery (Fig. 8). H&E staining revealed that
laminin mimetic YIGSR-PA (Fig. 8a) induced keratocyte migration
and stromal regeneration in the stromal dissection site without
any changes in the corneal morphology compared with native
Fig. 3. SEM, TEM and AFM images of (a–c) YIGSR-PA gel formed with E-PA, (d–f) KKRGD-PA gel formed with E-PA and (g–i) K-PA gel formed with E-PA.
Fig. 4. Proliferation results of corneal ﬁbroblasts at 72 h. The YIGSR-PA nanoﬁbers
exhibited a similar proliferation proﬁle on the HTK cell line compared with
collagen.
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case of ﬁbronectin-mimetic KKRGD-PA injection when inspected
3 weeks after surgery (Fig. 8e). In addition, there was no cell migra-
tion to the stromal dissection site in KKRGD-PA injected samples,
which was similar to corneal pocket without injection samples,
where no PA was injected (Fig. 8i). These results show that
laminin-mimetic YIGSR-PA was the driving factor for inducing
cellular migration to the stromal dissection site after surgery.The morphology and protein content of the stromal ECM were
further investigated by anti-collagen I and anti-vimentin immuno-
staining. Collagen forms 80% of the organic content of the corneal
stroma, and type I collagen is the most abundant collagenous
component contributing to corneal transparency through the
well-organized collagen I ﬁbrils [35]. In order to regenerate dam-
aged stroma, collagen I synthesis and lamellar organization of the
ﬁbrils is necessary. Thus, anti-collagen I staining was performed to
observe its synthesis and organization. Three weeks after surgery,
collagen I expression was observed in all groups. However,
although lamellar organization of collagen I in the corneal dissec-
tion area was similar in YIGSR-PA, non-dissected control group
and corneal pocket without injection group, the KKRGD-PA
injected samples exhibited a wavy organizational pattern, which
shows that the type of bioactive epitope is an important determi-
nant of the regeneration inducing capability of hydrogels formed
by PA molecules.
Anti-vimentin staining was performed to visualize the cells that
migrated to the corneal dissection site. Vimentin is an intermediate
ﬁlament protein and a well-known keratocyte marker. An
increased amount of cells migrated to the corneal dissection site
in the presence of YIGSR-PA injection in all four animals tested,
and these cells were positive for anti-vimentin staining. However,
no cell migration to the damaged area was observed in KKRGD-PA
injected animals (n = 3) and the corneal pocket without injection
group (n = 3) (Fig. 8g, k).
After corneal dissection, while some keratocytes undergo
apoptosis, others secrete ECM, which ﬁlls the gap in the damaged
Fig. 5. SEM images of the corneal ﬁbroblasts cultured on (a) YIGSR-PA-coated surface, (b) KKRGD-PA-coated surface, (c) K-PA-coated surface cultured and (d) collagen-coated
surface showing the adhesion proﬁles of cells.
Fig. 6. Spreading and cellular morphology of corneal ﬁbroblasts acquired by vimentin (blue), TRITC-conjugated phalloidin (red) and TO-PRO-3 (green) iodide staining on (a)
YIGSR-PA-coated surface, (b) KKRGD-PA-coated surface, (c) K-PA-coated surface cultured and (d) collagen-coated surface.
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induced keratocyte migration and collagen I expression, enhancingstroma regeneration 3 weeks after surgery. In the corneal pocket
without injection group, even though there was collagen I
Fig. 7. Representative images of injection process of KKRGD-PA: (a, b) damaging of stromas by corneal dissector; (c) image of cornea after KKRGD-PA molecule injection.
Asterisk indicates damaged area of corneal stroma, and arrow indicates the PA gels.
Fig. 8. IHC analyses of rabbit corneas at week 3. Sections from (a–d) YIGSR-PA-injected, (b–h) KKRGD-PA-injected and (i–l) corneal pocket without injection samples.
Asterisks indicate dissection area of corneal stroma, and arrows indicate the PA gels. Scale bars: (a), (e) and (i) 100 lm; (b), (c), (d), (f), (g), (h), (j), (k) and (l) 50 lm.
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tissue. A similar pattern was also observed for KKRGD-PA injected
corneas. Lack of cell migration into the peptide nanoﬁber gels inKKRGD-PA group suggests that the type of bioactive epitope that
is presented on the PA nanoﬁbers is important for achieving
keratocyte migration.
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IHC staining at 7 weeks after surgery. In YIGSR-PA injected sam-
ples, H&E staining as well as anti-collagen I and anti-vimentin
staining exhibited a similar proﬁle to that observed at week 3,
where keratocyte migration and collagen I synthesis was induced
(Fig. 9a, b). The cell migration proﬁle and collagen I organization
of the corneal pocket without injection group were also similar
to those observed at 3 weeks (Fig. 9e, f). However, KKRGD-PA in-
jected samples showed a different proﬁle at week 7 compared with
week 3, where collagenous lamellae were more organized and sim-
ilar to healthy cornea, although there was still no keratocyte
migration (Fig. 9i, j).
Comparison between anti-collagen I and anti-vimentin staining
of KKRGD-PA injected and corneal pocket without injection groups
revealed a similar healing process and no cell migration at week 7
(Fig. 9e–l), which further supports the importance of the type of
bioactivity that is displayed on the peptide nanoﬁbers on their
regeneration induction capability. Although the ﬁbronectin-
derived RGD sequence is a widely used bioactive, cell-adhesive
peptide, the presentation of this sequence on PA nanoﬁbers did
not induce cellular migration of keratocytes into the injection site
in the corneal regeneration model. The laminin-derived YIGSR
sequence is another widely used cell adhesive peptide and was
previously shown to enhance corneal regeneration when used
together with a collagen-containing copolymer [36]. When this
sequence was displayed on peptide nanoﬁber scaffolds, stromal
regeneration and keratocyte migration were enhanced in the pres-
ent study as well. Although RGD functionalized artiﬁcial scaffolds
were previously shown to support corneal ﬁbroblast activity [37],
the RGD functionalized peptide nanoﬁber system did not induce
similar activity in the present study, which suggests that theFig. 9. IHC analyses of rabbit corneas at week 7. Sections from (a–d) YIGSR-PA injected, (b
indicate dissection area of corneal stroma, and arrows indicate the PA gels. Scale bars: (scaffold material itself also might affect the bioactivity of the signal
sequences. Overall, the ease of injection of the PA solutions into the
corneal pocket, as well as versatility of the peptide sequences that
can be used in their design makes PA molecules attractive materi-
als for corneal tissue regeneration.
Studies on the regeneration of cornea have generally focused on
two approaches: one is in vitro production of cornea in culture, and
the other is in vivo regeneration of the cornea via use of tissue
engineered matrixes. In the ﬁrst approach, keratocytes and/or
ﬁbroblasts are directed to produce corneal ECM components in cell
culture media. Gaudreault et al. [38] stimulated dermal ﬁbroblasts
by ascorbic acid to produce ECM and collagen. ECM layers were
stacked together one above the other and further processed in cell
culture to form the corneal stroma. The primary problem in this
technique is that the time period to produce transplantable cornea
was too long [38]. Carrier et al. [39] used a combination of human
dermal ﬁbroblasts and keratocytes in corneal stroma production to
promote rapid and healthy epithelial healing. This approach en-
abled production of cultured corneal stroma with mechanical and
microstructural properties similar to native human cornea [39].
Guo et al. [40] cultured human keratocytes and stimulated them
to produce corneal ECM. Within 4 weeks, they produced 36-lm-
thick stroma similar to human corneal stroma [40]. Vrana et al.
[41] inserted keratocytes into the porous matrix containing colla-
gen and CS to produce corneal stroma, after which they implanted
epithelial and endothelial layers. With this approach, they were
able to produce all three layers of the cornea [41].
The second approach, which is in vivo regeneration of the cor-
nea via use of tissue engineered matrices, uses ECM properties that
direct cell proliferation and differentiation. Type 1 collagen matrix
was the most commonly researched macromolecule for in vivo–h) KKRGD-PA injected and (i–l) corneal pocket without injection samples. Asterisks
a), (e) and (i) 100 lm; (b), (c), (d), (f), (g), (h), (j), (k) and (l) 50 lm.
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lagen type 1 matrix into lamellar stroma similar to human corneal
stroma [42,43]. Recombinant human collagen type 1 and 3 (RHC1
and RHC3) containing ECM mimetics were implanted into animal
corneas using lamellar keratoplasty techniques [44]. After
12 months’ follow-up, both RHC1 and RHC3 integrated into the
animals’ corneas, and the corneas sustained their optical clarity.
Light microscopy and TEM revealed that corneal lamellar structure
was formed similar to native cornea. Upon these ﬁndings, human
study was started for 10 patients with keratoconus and stromal
scarring were included in the study. Parallel to the animal studies,
RHC integrated into the human corneas and corneas sustained
their optical clarity. Keratocytes settled into the collagen matrix
and converted it into lamellar corneal stroma [45]. In the present
work, YIGSR peptide nanoﬁber scaffold promoted keratocyte
migration into the scaffold, and the keratocytes converted the pep-
tide nanoﬁber matrix into the lamellar corneal stroma. Preserva-
tion of the optical clarity of the animal corneas together with
histological ﬁndings shows that peptide YIGSR-PA nanoﬁber
scaffolds can achieve corneal stroma regeneration without any
signiﬁcant injury to the cornea.
In clinical practice, injectable peptide nanoﬁber scaffolds have
several promising advantages over other corneal stromal regenera-
tion approaches. Injectable matrices may give ﬂexibility of
applications in corneal tissues. They could be used to ﬁll and regen-
erate a defect area of the cornea, especially in corneal diseases with
stromal thinning, such as keratoconus and pellucidmarginal degen-
eration. Addition of extra stromal tissue to the peripheral cornea
may also reverse myopic refractive errors; conversely, addition to
central cornea could reverse hypermetropic refractive errors.4. Conclusion
This study investigated the potential of peptide nanoﬁber
scaffolds decorated with bioactive laminin derived YIGSR and
ﬁbronectin RGD peptides for corneal regeneration. To the best of
the present authors’ knowledge, this is the ﬁrst time that peptide
nanoﬁber scaffolds have been used for corneal stroma regenera-
tion. Chemical and physiological characterization studies indicated
that all groups exhibited ECM mimicking nanoﬁbrous morphology
with b-sheet secondary structure, which was driven through self-
assembly of PA molecules. In vitro studies showed that PA nanoﬁ-
bers were biocompatible with the human stromal keratocyte cell
line, HTK cells, and supported their adhesion and viability. In
in vitro cell proliferation assays, laminin-mimetic YIGSR-PA nanof-
ibers showed an enhanced effect on cell proliferation compared
with other PA groups. The in vivo cornea damage model demon-
strated that the YIGSR-PA injection to the damage site induced
keratocyte migration and collagen I synthesis, which is an indica-
tion of corneal stroma regeneration. However, when presented
on PA nanoﬁbers, the ﬁbronectin-derived RGD sequence, which is
widely used for enhancing cell adhesion for various purposes, did
not show a similar effect to YIGSR-PA. Although collagen I synthe-
sis in the damage site was detected in the ﬁbronectin mimetic
peptide nanoﬁber injected samples and the corneal pocket without
injection controls, there was a striking absence of cells in the
damage area, which shows the importance of the type of bioactive
epitope for speciﬁc applications. In conclusion, the laminin
mimetic YIGSR functionalized peptide nanoﬁber system presents
a promising scaffold for corneal stroma regeneration.Acknowledgements
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